Catalyst’s Todd Clapp and Ryan McNally have joined the company’s board following the deal, while industry veteran Rick Jung has been named CEO.
He said, “We have a unique opportunity to support a rapidly expanding but broadly underserved market of clinical experts.
“I look forward to building on the fantastic work Jim has done, increasing our client base to assist more outpatient therapy businesses so they can focus their valuable resources on patient care.
Clapp added, “Clinicient’s fully-integrated solution and its deep domain expertise uniquely position the company to deliver tangible benefits to the outpatient rehabilitation sector and capture significant market share.
“We look forward to working with the Clinicient team and helping with the continued expansion of the business.”
Catalyst is currently investing from its third fund, making both minority and majority investments of up to $40m in rapidly growing companies.
Copyright © 2014 AltAssets